They confirmed that the risk of CBC in noncarriers of BRCA1/2 mutation with a family history was highest in women diagnosed at an earlier age with their index breast cancer (<45 years), those with a young first-degree relative, particularly with bilateral disease. This evidence concerns the gene BRCA1 and breast carcinoma.